Arkolith/Insider Trading/ASBP/Form 4/A

Fell Donald G.

DirectorAspire Biopharma Holdings, Inc. (ASBP) · full profile →Form 4/A · filed Jun 10, 2025
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2025Buy(P)11K$0.39$4K20K
Jun 4, 2025Buy(P)10K$0.39$4K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001641172-25-014569) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML